Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

Clinical trial NCT06789601 · RECRUITING

Trial details

NCT number: NCT06789601
Sponsor: Brigham and Women's Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignancy Immune Related Adverse Events

Start date: 2025-06-17
Primary completion: 2027-08-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.